Tokyo, Japan

Nobuyoshi Shimada


Average Co-Inventor Count = 5.4

ph-index = 6

Forward Citations = 67(Granted Patents)


Location History:

  • Tokyo, JA (1976)
  • Tokyo, JP (1983 - 1994)

Company Filing History:


Years Active: 1976-1994

Loading Chart...
16 patents (USPTO):Explore Patents

Sure, here is the article about inventor Nobuyoshi Shimada:

Title: Innovator Spotlight: Nobuyoshi Shimada

Introduction:

Nobuyoshi Shimada is a prolific inventor based in Tokyo, Japan, with a remarkable portfolio of 16 patents to his name. His groundbreaking work in the field of antiviral therapeutics has earned him recognition in the scientific community.

Latest Patents:

1. 2-halogeno-oxetanocin A and phosphoric ester thereof: Nobuyoshi Shimada's innovative patent involves the discovery of compounds with strong antiviral activity, specifically targeting viral diseases. These compounds demonstrate high residual activity and are not inactivated by adenosine deaminase present in living bodies.

2. Oxetanocins: Another notable patent by Shimada focuses on novel oxetanocins and their pharmacologically acceptable salts, which exhibit potent antiviral properties.

Career Highlights:

Nobuyoshi Shimada has made significant contributions while working at esteemed companies such as Nippon Kayaku Kabushiki Kaisha and the research institution Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. His innovative research has paved the way for advancements in antiviral drug development.

Collaborations:

Throughout his career, Shimada has collaborated with prominent researchers and scientists, including Shigeru Hasegawa and Seiichi Saito. These collaborations have enhanced the impact of his work and led to groundbreaking discoveries in the field of antiviral therapeutics.

Conclusion:

Nobuyoshi Shimada's dedication to innovation and his relentless pursuit of scientific advancements have cemented his reputation as a leading inventor in the field of antiviral drug development. His patented inventions continue to inspire further research and hold great promise for the future of antiviral treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…